Discover more insights into Amyloid Pet

Keywords frequently search together with Amyloid Pet

Narrow sentence examples with built-in keyword filters

Amyloid Pet sentence examples within mild cognitive impairment



β-Amyloid PET and 123I-FP-CIT SPECT in Mild Cognitive Impairment at Risk for Lewy Body Dementia



Clinical Implications of Amyloid-Beta Accumulation in Occipital Lobes in Alzheimer’s Continuum


Amyloid Pet sentence examples within positron emission tomography



Modifiable risk factors for dementia and dementia risk profiling. A user manual for Brain Health Services—part 2 of 6



Comparison of the Amyloid Load in the Brains of Two Transgenic Alzheimer’s Disease Mouse Models Quantified by Florbetaben Positron Emission Tomography


Amyloid Pet sentence examples within amyloid positron emission



Amyloid and APOE Status of Screened Subjects in the Elenbecestat MissionAD Phase 3 Program



[18F]FDG PET may differentiate cerebral amyloid angiopathy from Alzheimer’s disease




Amyloid Pet sentence examples within magnetic resonance imaging



Patterns of tau pathology identified with 18 F-MK-6240 PET imaging.



Accuracy of Tau Positron Emission Tomography as a Prognostic Marker in Preclinical and Prodromal Alzheimer Disease: A Head-to-Head Comparison Against Amyloid Positron Emission Tomography and Magnetic Resonance Imaging.


Amyloid Pet sentence examples within Positive Amyloid Pet



[18F]FDG PET may differentiate cerebral amyloid angiopathy from Alzheimer’s disease



Association between CSF Aβ42 and amyloid negativity in patients with different stage mild cognitive impairment


Amyloid Pet sentence examples within Abnormal Amyloid Pet



Plasma amyloid-β oligomerization assay as a pre-screening test for amyloid status



Frequency of Biologically Defined Alzheimer Disease in Relation to Age, Sex, APOE ε4, and Cognitive Impairment


Amyloid Pet sentence examples within Underwent Amyloid Pet



Patterns of tau pathology identified with 18 F-MK-6240 PET imaging.



Molecular pathology and synaptic loss in primary tauopathies: UCB-J PET study


Amyloid Pet sentence examples within Labeled Amyloid Pet



In vivo staging of regional amyloid progression in healthy middle-aged to older people at risk of Alzheimer’s disease



18F-florbetapir PET/MRI for quantitatively monitoring myelin loss and recovery in patients with multiple sclerosis: A longitudinal study


Amyloid Pet sentence examples within Flutemetamol Amyloid Pet



Early stages of tau pathology and its associations with functional connectivity, atrophy and memory.



Different aspects of Alzheimer’s disease-related amyloid β-peptide pathology and their relationship to amyloid positron emission tomography imaging and dementia


Amyloid Pet sentence examples within An Amyloid Pet



Diogenes syndrome in dementia: a case report



External validation of change formulae in neuropsychology with neuroimaging biomarkers: A methodological recommendation and preliminary clinical data


Amyloid Pet sentence examples within Phase Amyloid Pet



High Correlation of Static First-Minute-Frame (FMF) PET Imaging after 18F-Labeled Amyloid Tracer Injection with [18F]FDG PET Imaging



Quantitative Analysis of Brain 18F-fluordesoxyglucose and Early-Phase 18F-florbetapir Positron Emission Tomography


Amyloid Pet sentence examples within Florbetaben Amyloid Pet



Association of Dipeptidyl Peptidase-4 Inhibitor Use and Amyloid Burden in Patients With Diabetes and AD-Related Cognitive Impairment



Clinical Implications of Amyloid-Beta Accumulation in Occipital Lobes in Alzheimer’s Continuum


Amyloid Pet sentence examples within Pib Amyloid Pet



Associations of quantitative susceptibility mapping with Alzheimer’s disease clinical and imaging markers



Evaluation of [18F]-JNJ-64326067-AAA tau PET tracer in humans.


Amyloid Pet sentence examples within amyloid pet imaging



Brain 18F-Florbetapir PET/CT Findings in an Early-onset Alzheimer Disease Patient Carrying Presenilin-1 G378E Mutation.



Assessment of the Concordance and Diagnostic Accuracy Between Elecsys and Lumipulse Fully Automated Platforms and Innotest


Amyloid Pet sentence examples within amyloid pet scan



Cognitive change in frail individuals with intermediate amyloid load: Insight from the MAPT interventional study (+ Running poster)



Neuroimaging Biomarkers of Chronic Traumatic Encephalopathy: Targets for the Academic Memory Disorders Clinic.


Amyloid Pet sentence examples within amyloid pet image



Association of Dipeptidyl Peptidase-4 Inhibitor Use and Amyloid Burden in Patients With Diabetes and AD-Related Cognitive Impairment



Texture-Based Analysis of 18F-Labeled Amyloid PET Brain Images


Amyloid Pet sentence examples within amyloid pet positivity



Association Between Plasma Amyloid-β and Neuropsychological Performance in Patients With Cognitive Decline



Head Injury Exposure in Veterans Presenting to Memory Disorders Clinic: An Observational Study of Clinical Characteristics and Relationship of Event-Related Potentials and Imaging Markers


Amyloid Pet sentence examples within amyloid pet tracer



Prionopathies and Prionlike Protein Aberrations in Neurodegenerative Diseases



Direct comparison of the tau PET tracers [18F]flortaucipir and [18F]MK-6240 in human subjects.


Amyloid Pet sentence examples within amyloid pet result



CLINICAL UTILITY OF β-AMYLOID PET IMAGING IN PEOPLE LIVING WITH HIV WITH COGNITIVE SYMPTOMS.



Response to “Avoiding Methodological Bias in Studies of Amyloid Imaging Results Disclosure”


Amyloid Pet sentence examples within amyloid pet suvr



Impact of Reference and Target Region Selection on Amyloid PET SUV Ratios in the Phase 1b PRIME Study of Aducanumab



Financial Management Skills in Aging, MCI and Dementia: Cross Sectional Relationship to 18F-Florbetapir PET Cortical β-amyloid Deposition


Amyloid Pet sentence examples within amyloid pet ligand



TRIAL DESIGN, DATA SHARING RISK MITIGATION, AND BASELINE CLINICAL AND COGNITIVE DATA FROM THE API AUTOSOMAL DOMINANT ALZHEIMER’S DISEASE COLOMBIA TRIAL



SELECTIVITY OF PET AMYLOID IMAGING LIGANDS IN THE ALZHEIMER’S DISEASE NEUROPATHOLOGY SPECTRUM


Amyloid Pet sentence examples within amyloid pet study



Cerebral amyloid angiopathy-related inflammation: clinical features and treatment response in a case series.



A pitfall of white matter reference regions used in [18F] florbetapir PET: a consideration of kinetics


Amyloid Pet sentence examples within amyloid pet quantification



Impact of image processing on [11C]PIB amyloid quantification



Improved quantification of amyloid burden and associated biomarker cut-off points: results from the first amyloid Singaporean cohort with overlapping cerebrovascular disease


Amyloid Pet sentence examples within amyloid pet statu



Plasma amyloid-β oligomerization assay as a pre-screening test for amyloid status



Promising Diagnostic Accuracy of Plasma GFAP and NfL Within The AD Continuum


More Amyloid Pet sentence examples
10.1007/s12149-021-01634-3

Effect of different examination conditions on image quality and quantitative value of amyloid positron emission tomography using 18F-flutemetamol


More Amyloid Pet sentence examples
10.7759/cureus.13481

Discordance Between Cerebrospinal Fluid Biomarkers and Amyloid Positron Emission Tomography in Alzheimer’s Sheds Light on Clinical Trial Exclusion Criteria


More Amyloid Pet sentence examples
10.1097/WAD.0000000000000461

Brain 18F-Florbetapir PET/CT Findings in an Early-onset Alzheimer Disease Patient Carrying Presenilin-1 G378E Mutation.


More Amyloid Pet sentence examples
10.1212/WNL.0000000000011226

Plasma Tau and Neurofilament Light in Frontotemporal Lobar Degeneration and Alzheimer Disease


More Amyloid Pet sentence examples
10.1007/s13311-021-01028-3

Neuroimaging Biomarkers of Chronic Traumatic Encephalopathy: Targets for the Academic Memory Disorders Clinic.


More Amyloid Pet sentence examples
10.14283/jpad.2021.39

Cohort-Specific Optimization of Models Predicting Preclinical Alzheimer’s Disease, to Enhance Screening Performance in the Middle of Preclinical Alzheimer’s Disease Clinical Studies


More Amyloid Pet sentence examples
10.3389/fnagi.2021.736937

Association Between Plasma Amyloid-β and Neuropsychological Performance in Patients With Cognitive Decline


More Amyloid Pet sentence examples
10.1016/j.nrl.2020.12.008

Cerebral amyloid angiopathy-related inflammation: clinical features and treatment response in a case series.


More Amyloid Pet sentence examples
10.3389/fneur.2021.626767

Head Injury Exposure in Veterans Presenting to Memory Disorders Clinic: An Observational Study of Clinical Characteristics and Relationship of Event-Related Potentials and Imaging Markers



Comparing CSF amyloid‐beta biomarker ratios for two automated immunoassays, Elecsys and Lumipulse, with amyloid PET status


More Amyloid Pet sentence examples
10.1007/978-3-030-51140-1_7

Neuroimaging in Frontotemporal Lobar Degeneration: Research and Clinical Utility.


More Amyloid Pet sentence examples
10.2967/jnmt.120.261701

Improved Accuracy of Amyloid PET Quantification with Adaptive Template–Based Anatomic Standardization



More Atypical than Atypical Alzheimer’s Disease Phenotypes: A Treviso Dementia (TREDEM) Registry Case Report


More Amyloid Pet sentence examples
10.1093/brain/awaa403

Population-based blood screening for preclinical Alzheimer’s disease in a British birth cohort at age 70



P‐tau/Aβ42 and Aβ42/40 ratios in CSF are equally predictive of amyloid PET status


More Amyloid Pet sentence examples
10.21203/rs.3.rs-643725/v1

Amyloid PET Quantification Using Low-dose CT-guided Anatomic Standardization


More Amyloid Pet sentence examples
10.1007/s00259-020-05151-9

True ultra-low-dose amyloid PET/MRI enhanced with deep learning for clinical interpretation



Cortical [18 F]PI-2620 Binding Differentiates Corticobasal Syndrome Subtypes.


More Amyloid Pet sentence examples
10.1212/WNL.0000000000012770

Cerebral Amyloid Angiopathy Pathology and Its Association With Amyloid-β PET Signal.


More Amyloid Pet sentence examples
10.14283/jpad.2021.8

Item-Level Investigation of Participant and Study Partner Report on the Cognitive Function Index from the A4 Study Screening Data


More Amyloid Pet sentence examples
10.14283/jpad.2021.45

Aducanumab: Appropriate Use Recommendations


More Amyloid Pet sentence examples
10.1186/s13195-021-00807-6

Early detection of amyloid load using 18F-florbetaben PET



Texture-Based Analysis of 18F-Labeled Amyloid PET Brain Images


More Amyloid Pet sentence examples
10.2967/jnumed.120.254961

Direct comparison of the tau PET tracers [18F]flortaucipir and [18F]MK-6240 in human subjects.


More Amyloid Pet sentence examples
10.1148/radiol.2021210383

Diffusion Tensor MRI Structural Connectivity and PET Amyloid Burden in Preclinical Autosomal Dominant Alzheimer Disease: The DIAN Cohort.


More Amyloid Pet sentence examples
10.6009/jjrt.2021_JSRT_77.1.32

[Cross-validation of Quantitative Analytical Software Using 18F-florbetapir PET Imaging].



Plasma Amyloid-β Oligomerization Tendency Predicts Amyloid PET Positivity


More Amyloid Pet sentence examples
10.1007/s00259-021-05311-5

A multisite analysis of the concordance between visual image interpretation and quantitative analysis of [18F]flutemetamol amyloid PET images


More Amyloid Pet sentence examples
10.3389/fnins.2021.598234

Parametric Estimation of Reference Signal Intensity for Semi-Quantification of Tau Deposition: A Flortaucipir and [18F]-APN-1607 Study


More Amyloid Pet sentence examples
10.1007/s00259-021-05485-y

The approval of a disease-modifying treatment for Alzheimer’s disease: impact and consequences for the nuclear medicine community


More Amyloid Pet sentence examples
10.1186/s13195-021-00894-5

Is comprehensiveness critical? Comparing short and long format cognitive assessments in preclinical Alzheimer disease


More Amyloid Pet sentence examples
10.1001/jamaneurol.2021.1893

Association of Apolipoprotein E ɛ4 Allele With Clinical and Multimodal Biomarker Changes of Alzheimer Disease in Adults With Down Syndrome.


More Amyloid Pet sentence examples
10.1038/s41598-021-91891-z

Early-phase 18F-FP-CIT and 18F-flutemetamol PET were significantly correlated



A Novel ITM2B Mutation Associated with Familial Chinese Dementia.


More Amyloid Pet sentence examples
10.1371/journal.pone.0244893

Effect of aerobic exercise on amyloid accumulation in preclinical Alzheimer’s: A 1-year randomized controlled trial


More Amyloid Pet sentence examples
10.15252/emmm.202114022

Soluble P‐tau217 reflects amyloid and tau pathology and mediates the association of amyloid with tau


More Amyloid Pet sentence examples
10.1186/s13550-021-00798-3

Deep learning-based amyloid PET positivity classification model in the Alzheimer’s disease continuum by using 2-[18F]FDG PET



Cerebral amyloid angiopathy distribution in older people: A cautionary note


More Amyloid Pet sentence examples
10.1186/s13195-021-00787-7

Cognitive trajectories of patients with focal ß-amyloid deposition


More Amyloid Pet sentence examples
10.1126/scitranslmed.abj2511

In vivo and neuropathology data support locus coeruleus integrity as indicator of Alzheimer’s disease pathology and cognitive decline


More Amyloid Pet sentence examples
10.1186/s13195-021-00819-2

Strategies to reduce sample sizes in Alzheimer’s disease primary and secondary prevention trials using longitudinal amyloid PET imaging


More Amyloid Pet sentence examples
10.1016/j.nicl.2020.102553

Lack of association between acute stroke, post-stroke dementia, race, and β-amyloid status



SimPET—An open online platform for the Monte Carlo simulation of realistic brain PET data. Validation for 18F‐FDG scans


More Amyloid Pet sentence examples
10.1186/s13024-021-00451-6

A blood-based diagnostic test incorporating plasma Aβ42/40 ratio, ApoE proteotype, and age accurately identifies brain amyloid status: findings from a multi cohort validity analysis


More Amyloid Pet sentence examples
10.1212/WNL.0000000000012775

Predicting Symptom Onset in Sporadic Alzheimer Disease With Amyloid PET.


More Amyloid Pet sentence examples
10.1097/QAI.0000000000002648

CLINICAL UTILITY OF β-AMYLOID PET IMAGING IN PEOPLE LIVING WITH HIV WITH COGNITIVE SYMPTOMS.


More Amyloid Pet sentence examples
10.1136/jnnp-2021-bnpa.21

#3041 High prevalence of lifetime depressive symptoms in patients referred for clinical amyloid-PET: a retrospective study


More Amyloid Pet sentence examples
10.21203/RS.3.RS-101153/V2

Soluble P-tau217 reflects amyloid and tau pathology and mediates the association of amyloid with tau


More Amyloid Pet sentence examples
10.3389/fnagi.2021.672077

Association of Tau Pathology With Clinical Symptoms in the Subfields of Hippocampal Formation


More Amyloid Pet sentence examples
10.1016/j.jocn.2021.06.017

The role of amyloid PET in patient selection for extra-ventricular shunt insertion for the treatment of idiopathic normal pressure hydrocephalus: A pooled analysis



Prognostic Impact of 18-F-Florbetaben Amyloid PET Imaging in Patients with Isolated Increases in Cerebrospinal Fluid Phospho-Tau Biomarkers: A Longitudinal Study.


More Amyloid Pet sentence examples
10.1089/brain.2020.0808

Resting-State Functional Connectivity Disruption as a Pathological Biomarker in Autosomal Dominant Alzheimer Disease



Amyloid Pet
Encyclopedia